An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action.
about
Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.Molecular targets for antiepileptic drug developmentEvidence-Based Treatments for Adults with MigraineEvidence-based treatments for cluster headacheNeuroprotective Strategies after Neonatal Hypoxic Ischemic EncephalopathyPharmacotherapy for Status EpilepticusNovel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulationPharmacological treatment of comorbid PTSD and substance use disorder: recent progressTopiramate treatment is neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injuryTopiramate in the Treatment of Generalized Convulsive Status Epilepticus in Adults: A Systematic Review with Individual Patient Data AnalysisThe efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models.Medication treatment of different types of alcoholism.Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.The safety and tolerability of newer antiepileptic drugs in children and adolescents.Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder.New data suggest that discontinuation of status epilepticus is not necessary for antiepileptogenic effect in immature brainAnalgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.Neonatal seizures: an update on mechanisms and managementDevelopmental factors in the pathogenesis of neonatal seizuresComprehensive review of visual defects reported with topiramateReview of topiramate for the treatment of epilepsy in elderly patients.Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headacheNew directions in migraineFamilial vulnerability to an unusual cognitive adverse effect of topiramate: Discussion of mechanisms.Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.Topiramate modulates habituation in migraine: evidences from nociceptive responses elicited by laser evoked potentialsPharmacotherapy for treatment-resistant schizophrenia.Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model.Topiramate hyperpolarizes and modulates the slow poststimulus AHP of rat olfactory cortical neurones in vitro.Enteral topiramate in a pediatric patient with refractory status epilepticus: a case report and review of the literature.New drugs for the treatment of epilepsy: a practical approachACS chemical neuroscience molecule spotlight on QnexaPhosphorylation of sodium channels mediated by protein kinase-C modulates inhibition by topiramate of tetrodotoxin-sensitive transient sodium currentPatient outcome in migraine prophylaxis: the role of psychopharmacological agentsVersatility of the mouse reversal/set-shifting test: effects of topiramate and sexThe novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injuryPhentermine and topiramate for the management of obesity: a review.Preventive treatment in migraine and the new US guidelinesTopiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity.
P2860
Q24632593-02AB17C2-E183-4BD3-A35C-9EAD7E2D7D20Q24683346-5BDBF276-3CE8-4FC0-9B20-FB86C3689C16Q26769968-D22F87E2-A632-4A2D-8C4D-2ABEB8D8FF39Q26774849-ECC4A6DD-DD62-45DE-91A0-5BC0AE0E6443Q26782756-7FEA9C5D-818A-4727-AFAD-27895EB23FFDQ26796689-F6065CCF-B989-42AB-ABD9-69EBBF1EE9ACQ26853630-4718C3C4-B689-44D8-BC15-E9703FCEFCF0Q27022219-126AAA59-3191-4FC1-8747-601D696A0481Q27306821-0B8FF88D-4639-4CA6-A1DF-87D7E048D0A4Q30396733-AE7859B4-2A4B-410D-99C8-B228CD4148C3Q30408902-0EF17B38-E339-44D5-A0FA-893F6F7A45CAQ30434793-02F82E23-D7A0-41FE-A379-E92B1E81790CQ30440516-6464598E-0029-4BC1-93C0-DD450A77D78AQ30454834-C283F636-5256-40E3-9016-574945C86888Q30462209-2E60523A-9380-4BA8-BD96-5CD95DFCD8BDQ30488880-7ABB9DA6-FD80-45ED-A327-030033DF2713Q33270667-B335F7B0-8E2F-445F-80B9-322087E456C0Q33621804-F4D17142-20B6-4C2B-8899-2A28BDF3EE26Q33639690-9495D949-001A-4968-89E7-F72171626CE1Q33688474-B8C4EA99-FB43-4B4A-A932-117A7593A866Q33739946-02554A6C-6516-44BE-A952-29A66604829AQ33819386-96AB3D85-9B2C-4C4E-B5E0-73E8D077A3FBQ33921986-618C0F74-04F1-4358-BFE3-F4A0DA5707B9Q34057763-9191D7D6-7B4F-4388-9BED-114B0CDA294CQ34345252-654E6379-906E-40F3-965C-9E3F7B97A4B3Q34458158-DEACD673-CB5C-4E3D-BB9A-D755B9FEDB18Q34659264-AC3A2F89-B1C7-497F-90EC-FC441793F015Q34879109-469D3384-3969-4D64-A69B-78DE421BD6BAQ34946029-D312EB86-8F55-41C8-BA85-C1583662CE51Q35046075-290C3AEB-8F11-4618-AE92-CCF73F57F988Q35124132-FA2FB940-52E1-4114-941A-B063E29C21DFQ35520425-614570A6-F3D5-454B-A191-A21C9B624B8AQ36015402-11C6847F-3DB3-4EAD-BA97-82DF0638F4B7Q36052542-5A3FCB6F-2371-4D22-85BD-C9FFA6657316Q36160565-CCE6836B-6705-49D7-ABEB-804FE655D70AQ36301405-4A3A6A35-D129-4C66-8B0D-3BD4D33A7BD4Q36649718-0DC8A878-BFA5-4176-9EE3-7F0E22AE5842Q36758207-EDC2FEF2-ACE6-4DF5-A76F-47C424EE91A6Q36873484-7D0DC78B-6A8E-43B4-A84F-1449DA96FAD4Q36999739-6770454F-4B1A-4232-8964-3FAAB112F261
P2860
An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
An overview of the preclinical ...... tics, and mechanism of action.
@ast
An overview of the preclinical ...... tics, and mechanism of action.
@en
type
label
An overview of the preclinical ...... tics, and mechanism of action.
@ast
An overview of the preclinical ...... tics, and mechanism of action.
@en
prefLabel
An overview of the preclinical ...... tics, and mechanism of action.
@ast
An overview of the preclinical ...... tics, and mechanism of action.
@en
P2093
P1433
P1476
An overview of the preclinical ...... tics, and mechanism of action.
@en
P2093
A J Streeter
B E Maryanoff
J F Gardocki
P2860
P356
10.1111/J.1528-1157.2000.TB06045.X
P478
41 Suppl 1
P577
2000-01-01T00:00:00Z